Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global ...

Eli Lilly (NYSE:LLY) has already manufactured billions of doses of its next-generation weight-loss pill, anticipating strong ...

A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The manufacturer, Eli Lilly, says the drug, which is not yet licensed, could be ...

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...

An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy. The Eli Lilly drug, called ...

Over the last four years, weight-loss drugs that dampen down appetite and promote satiety have revolutionised obesity medicine. They are currently being taken by 1.5 million peopl ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.

Popular weight loss drugs are now available at a discount for Sam's Club and Costco shoppers without insurance. The deals ...

There’s never a dull day in the world of weight-loss medication. This week brought new restrictions on compounded GLP-1 medication, the cheaper, copycat versions of brand-name drugs that telehealth ...